Literature DB >> 4794904

Determination of pharmacological constants: use of narcotic antagonists to characterize analgesic receptors.

A E Takemori.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4794904

Source DB:  PubMed          Journal:  Adv Biochem Psychopharmacol        ISSN: 0065-2229


× No keyword cloud information.
  7 in total

1.  Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys.

Authors:  C P France; G Winger; M R Seggel; K C Rice; J H Woods
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail-withdrawal assay.

Authors:  E A Walker
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

3.  Analgesia and serum concentrations of extradural, subdural and intraperitoneal fentanyl in a rat model.

Authors:  L Immelman; S Roth; M A Sabourin; L Strunin
Journal:  Can J Anaesth       Date:  1990-01       Impact factor: 5.063

4.  Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.

Authors:  M C Ko; E R Butelman; J R Traynor; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

5.  In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine.

Authors:  E A Walker; T M Richardson; A M Young
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

6.  Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.

Authors:  Caren L Steinmiller; Alice M Young
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

7.  In vivo Schild regression analyses using nonselective 5-HT2C receptor antagonists in a rat operant behavioral assay.

Authors:  Ellen A Walker; Edward K Brown; Steven N Sterious
Journal:  Psychopharmacology (Berl)       Date:  2007-04-01       Impact factor: 4.415

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.